Biocon Malaysia unit receives EU GMP certification
Singapore, Aug. 23 -- Biocon Ltd , Asia's premier biopharmaceuticals company, Biocon Ltd has announced that it's subsidiary in Malaysia, Biocon Sdn. Bhd., which operates Asia's largest integrated Insulins facility, received the Certificate of GMP compliance from the European Medicines Agency from the representative European inspection authority, Health Products Regulatory Authority (Ireland). This approval expands Biocon's capacities multi-fold with the new large scale devices facility coming up to speed to serve the growing needs of people with diabetes in EU.
The Malaysia site was inspected in May 2019 and the certificate of GMP compliance received now reflects that the agency considers the manufacturing facilities for Drug Substances,...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.